Metastatic type A thymoma: morphological and genetic correlation

The vast majority of type A thymomas are diagnosed in tumour stages 1 or 2, and metastatic cases are exceedingly rare. The histological and genetic features of such metastatic type A thymomas have not been described in detail.

[1]  A. Marx,et al.  Myf5 and Myogenin in the development of thymic myoid cells — Implications for a murine in vivo model of myasthenia gravis , 2016, Experimental Neurology.

[2]  F. Venuta,et al.  Does myasthenia gravis influence overall survival and cumulative incidence of recurrence in thymoma patients? A Retrospective clinicopathological multicentre analysis on 797 patients. , 2015, Lung cancer.

[3]  A. Nicholson,et al.  Type A and AB thymomas: histological features associated with increased stage , 2015, Histopathology.

[4]  M. Ladanyi,et al.  Massively Parallel Sequencing Identifies Recurrent Mutations in TP53 in Thymic Carcinoma Associated with Poor Prognosis , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  A. Nicholson,et al.  The Impact of Thymoma Histotype on Prognosis in a Worldwide Database , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  P. Meltzer,et al.  Mutations of epigenetic regulatory genes are common in thymic carcinomas , 2014, Scientific Reports.

[7]  Jaime Rodriguez-Canales,et al.  A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors , 2014, Nature Genetics.

[8]  S. Badve,et al.  The prognostic value of architectural patterns in a study of 37 type AB thymomas , 2014, Modern Pathology.

[9]  N. Girard,et al.  ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  S. Badve,et al.  A Gene Signature to Determine Metastatic Behavior in Thymomas , 2013, PloS one.

[11]  S. Badve,et al.  The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases , 2013, Modern Pathology.

[12]  P. Meltzer,et al.  Copy Number Aberrations of Genes Regulating Normal Thymus Development in Thymic Epithelial Tumors , 2013, Clinical Cancer Research.

[13]  J. Rosai,et al.  Is There a Spectrum of Cytologic Atypia in Type A Thymomas Analogous to That Seen in Type B Thymomas? A Pilot Study of 13 Cases , 2012, The American journal of surgical pathology.

[14]  C. Dass,et al.  Regulation of MT1-MMP and MMP-2 by the Serpin PEDF: a Promising New Target for Metastatic Cancer , 2012, Cellular Physiology and Biochemistry.

[15]  C. Enders,et al.  Common genomic aberrations in basaloid squamous cell carcinoma and carcinosarcoma of the esophagus detected by CGH and array CGH. , 2011, American journal of clinical pathology.

[16]  S. Badve,et al.  WHO types A and AB thymomas: not always benign , 2010, Modern Pathology.

[17]  S. Suster,et al.  Invasive spindle cell thymomas (WHO Type A): a clinicopathologic correlation of 41 cases. , 2010, American journal of clinical pathology.

[18]  A. Marchevsky,et al.  World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study group. , 2010, Human pathology.

[19]  N. Girard,et al.  Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas , 2009, Clinical Cancer Research.

[20]  P. Bejarano.  Evidence-Based Pathology and the Pathologic Evaluation of Thymomas: Transcapsular Invasion Is Not a Significant Prognostic Feature , 2009 .

[21]  S. Suster,et al.  Evidence-based pathology and the pathologic evaluation of thymomas: transcapsular invasion is not a significant prognostic feature. , 2008, Archives of pathology & laboratory medicine.

[22]  Woo Ick Yang,et al.  Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review. , 2005, Chest.

[23]  H. Müller-Hermelink,et al.  Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  K. Kondo,et al.  WHO histologic classification is a prognostic indicator in thymoma. , 2004, The Annals of thoracic surgery.

[25]  A. Marx,et al.  New WHO histologic classification predicts prognosis of thymic epithelial tumors , 2002, Cancer.

[26]  A. Rosenwald,et al.  Recurrent genetic aberrations in thymoma and thymic carcinoma. , 2000, The American journal of pathology.